PCI Biotech granted Orphan Drug Designation of fimaporfin for treatment of cholangiocarcinoma in EU NewsRonny SkuggedalAugust 29, 2016
Invitation to second quarter and first half year 2016 presentation NewsRonny SkuggedalAugust 24, 2016
Publication of the fimaporfin (Amphinex) first-in-man Phase I study in Lancet Oncology NewsRonny SkuggedalJuly 28, 2016
PCI Biotech receives positive opinion for Orphan Drug Designation of fimaporfin for treatment of cholangiocarcinoma in EU NewsRonny SkuggedalJuly 26, 2016
Pre-clinical research collaboration agreement with top-10 large pharma company extended NewsRonny SkuggedalMay 26, 2016
PCI Biotech: Fourth quarter and preliminary full year 2015 results NewsRonny SkuggedalFebruary 9, 2016
PCI Biotech and Ultimovacs initiates preclinical research collaboration NewsRonny SkuggedalJanuary 27, 2016
Dose escalation in the bile duct cancer study completed with promising early signs of efficacy NewsRonny SkuggedalJanuary 22, 2016
